Navigation Links
Marshall University study may lead to new treatments for prostate cancer
Date:3/21/2012

A recent study conducted at Marshall University may eventually help scientists develop new treatments for prostate cancer, the most common malignancy in American men.

The study, which focused on the effects of cadmium on the prostate, was conducted by Dr. Pier Paolo Claudio, an associate professor in the Biomedical Sciences Graduate Program and Department of Biochemistry and Microbiology at the university's Joan C. Edwards School of Medicine, and an international team of colleagues from the University of L'Aquila and the National Cancer Institute in Italy, and the University of Colorado Denver and the National Institute of Environmental Health Sciences in the United States.

An extremely toxic metal found in industrial workplaces, cadmium is commonly used in electroplating and is a key component in batteries and some paints. It is also found in cigarettes and some food supplies.

According to Claudio, scientists believe the prostate may be a target for cancer caused by cadmium, although the underlying mechanisms have been unclear.

"In our study, we investigated the effects of cadmium exposure in normal and in tumor cells derived from human prostate tissue," he said. "We were able to demonstrate the molecular mechanisms cadmium uses to induce carcinogenesis in the prostate."

Claudio, who said he has spent the last 15 years conducting research to understand the crosstalk between the factors that contribute to cancer progression versus those that protect from it, says this study is important because once those molecular mechanisms are understood, new therapies can be tailored to treat prostate cancer.

He added, "The focus of work in our laboratory is to understand the molecular mechanisms governing malignant transformation in order to tailor novel therapeutic strategies. To effectively design novel biological drugs, a thorough understanding of the mechanism of cancer pathogenesis is required. Our study will
'/>"/>

Contact: Ginny Painter
ginny.painter@marshall.edu
304-746-1964
Marshall University Research Corporation
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Breast cancer risk drops when diet includes walnuts, Marshall researchers find
2. Cystic Fibrosis Foundation funds Marshall research
3. Marshall University researchers awarded more than $1 million for breast cancer studies
4. LLNL research at Marshall Islands could lead to resettlement
5. Research at Marshall University may lead to new ways to transport and manipulate molecules
6. BGI, University of Helsinki and Wuhan University sign a MOU concerning cooperation on genomics
7. University of Alberta led research may have discovered how memories are encoded in our brains
8. University of Houston study shows BP oil spill hurt marshes, but recovery possible
9. University of Tennessee researchers invent device to rapidly detect infectious disease
10. Mayor Gray, University presidents pledge to make DC the Greenest College Town in America
11. American College and University Presidents Climate Commitment to meet at Arizona State University
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Marshall University study may lead to new treatments for prostate cancer
(Date:3/2/2015)... , March 2, 2015 Synaptics Inc. ... of human interface solutions, today announced a new ... designed to enable rapid and secure transactions and ... for gaming is a turnkey solution providing mouse ... to quickly integrate fingerprint ID solutions into their ...
(Date:3/2/2015)...   Neurotechnology , a provider of high-precision biometric, ... Software Development Kit (SDK). The SentiGaze algorithm enables ... webcams to track eye movements and generate heatmaps based ... can be used for applications such as analysis of ... SDK can also be used to develop interfaces for ...
(Date:2/24/2015)... This report analyzes the worldwide markets for Iris Biometrics in ... US, Canada , Japan ... , Middle East , and ... for the period 2013 through 2020. Also, a seven-year historic ... are derived from primary and secondary research. Company profiles are ...
Breaking Biology News(10 mins):Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11
... the western Antarctic Peninsula since 1850 The ... over the past 50 years (the period of observational ... on the fringes of the peninsula disintegrating. Despite this, ... of days with snowfall has increased by at least ...
... MD The Biophysical Society has announced the speakers for ... of the Biophysical Society and the International Biophysics Congress ... The new and notable symposium highlights the latest and ... and selected by the Societys program committee. The ...
... is a tiny yet insidious waterborne parasite that wreaks ... diarrhea and malnutrition in small children in developing countries, ... compromised patients in the developed world. Cryptosporidium is resistant ... the U.S., which has led to the concern that ...
Cached Biology News:AGU journal highlights -- Jan. 28, 2008 2AGU journal highlights -- Jan. 28, 2008 3AGU journal highlights -- Jan. 28, 2008 4AGU journal highlights -- Jan. 28, 2008 5AGU journal highlights -- Jan. 28, 2008 6Biophysical Society announces new and notable symposium speakers 2Breakthrough research turns the tide on water-borne pathogen 2
(Date:3/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4ld5nw/mature_biotech ) ... Outlook 2015: New Therapy Ventures Pave the Way for ... All biotech companies - Gilead (GILD), Amgen (AMGN), Biogen ... given a positive return and hence increased the interest ... select therapy/niche indication where the high treatment cost justifies ...
(Date:3/5/2015)... The next implants made from the ... mark (European) approval. The CE mark is necessary for ... and the European Union. Following the Class IIb approval ... implants supplied by the Turkey-based company Osimplant for the ... Cervical Expandable Bladed HA PEEK Cage line of spinal ...
(Date:3/4/2015)... -- In an article published and posted online today, ... review the clinical aspects of diseases caused by 5 ... article, "Clinical Management of Potential Bioterrorism-Related Conditions," was published ... New England Journal of Medicine . ... Tom Inglesby—review the clinical management of conditions resulting from ...
(Date:3/4/2015)... BARBARA, CALIFORNIA (PRWEB) March 04, 2015 ... consulting firm in the life sciences industry, hired ... Blewitt leads the Cloud Compliance Services and Solutions ... companies utilize cloud based applications while maintaining compliance with ... years, Blewitt has been an accomplished life sciences regulatory ...
Breaking Biology Technology:Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3Latest Clinical Information On Bioterrorism Threats 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3
... now at 15, SANTA CRUZ, Calif., Sept. 30 ... board and careers tool site for life-science,professionals, Bio Career ... two new schools -- the University of Texas M.,D. ... adding these two schools to the site, we are ...
... Inc. (OTC,Bulletin Board: BTEL) announced results for the year ... $0.23 per diluted share, on revenues of,$11,495,000. This compares ... revenues of $11,233,000 for the prior year. For its ... $0.07 per diluted share, on,revenues of $3,187,000. This compares ...
... - Oncolytics Biotech Inc.,(TSX: ONC, NASDAQ: ONCY) ... U.S. Patent 7,429,485 entitled "Method of Producing ... reassorted reovirus from,an FDA-approved cell line., ... of producing,reassorted reovirus," said Mary Ann Dillahunty, ...
Cached Biology Technology:Two Top-Ranking Schools Join Jobs Board Site 2Biotel Announces Record Revenues and Earnings for Fiscal 2008 2Oncolytics Biotech Inc. Announces Issuance of 28th U.S. Patent 2
... Exonuclease III digests duplex DNA in a ... 5'-overhang or nick, producing stretches of single-stranded ... by Exonuclease III proceeds at a uniform ... the rate of exonucleolytic excision of deoxyribonucleotides ...
... Klenow fragment is a ... coli DNA Polymerase I ... -> 5 exonuclease activity, but ... activity. Klenow retains the polymerization ...
... degrades, as an endoribonuclease, the RNA ... of natural origin, e.g. that of ... e.g. poly(A) x poly(dT). RNase H ... termini. Nearly no activity is detected ...
... E. coli strain containing an overproducing clone of ... the formation of a phosphodiester bond between juxtaposed ... DNA or RNA. It repairs single-stranded nicks in ... join both blunt-end and cohesive-end fragments of duplex ...
Biology Products: